Biotech’s three biggest innovators

Investors can find a wide range of profitable stocks in the biotech sector. Professional investor Dr Daniel Koller tips three to buy now.

Each week, a professional investor tells MoneyWeek where he'd put his money now. This week:Dr Daniel Koller, head of BB Biotech, Bellevue Asset Management.

The biotechnology sector has reached a certain level of maturity. In the early years, the only companies that investors had to choose from were highly speculative punts in small unproven start-ups. These days there is a wide range of profitable and well-run biotech companies to invest in.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

Dr Daniel Koller is head of BB Biotech at Bellevue Asset Management and resides in Zurich, Switzerland. He occasionally writes for MoneyWeek online and print and gives his share tips.